Expanding the clinical and immunological phenotypes of PAX1-deficient SCID and CID patients

Clin Immunol. 2023 Oct:255:109757. doi: 10.1016/j.clim.2023.109757. Epub 2023 Sep 9.

Abstract

Paired box 1 (PAX1) deficiency has been reported in a small number of patients diagnosed with otofaciocervical syndrome type 2 (OFCS2). We described six new patients who demonstrated variable clinical penetrance. Reduced transcriptional activity of pathogenic variants confirmed partial or complete PAX1 deficiency. Thymic aplasia and hypoplasia were associated with impaired T cell immunity. Corrective treatment was required in 4/6 patients. Hematopoietic stem cell transplantation resulted in poor immune reconstitution with absent naïve T cells, contrasting with the superior recovery of T cell immunity after thymus transplantation. Normal ex vivo differentiation of PAX1-deficient CD34+ cells into mature T cells demonstrated the absence of a hematopoietic cell-intrinsic defect. New overlapping features with DiGeorge syndrome included primary hypoparathyroidism (n = 5) and congenital heart defects (n = 2), in line with PAX1 expression during early embryogenesis. Our results highlight new features of PAX1 deficiency, which are relevant to improving early diagnosis and identifying patients requiring corrective treatment.

Keywords: Hypoparathyroidism; Inborn errors of immunity; Otofaciocervical syndrome; PAX1; SCID; thymus.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Paired Box Transcription Factors* / genetics
  • Phenotype
  • Severe Combined Immunodeficiency* / genetics
  • T-Lymphocytes
  • Thymus Gland

Substances

  • Paired Box Transcription Factors